Healthcare news

Featured image of the article BioNTech, promising results in a clinical trial with a bispecific antibody therapy to treat breast cancer (BNT327).

BioNTech, promising results in a clinical trial with a bispecific antibody therapy to treat breast cancer (BNT327)

Posted on by

SOPHIA ANTIPOLIS, France – February 04, 2025 │ Advancements in oncology have consistently pushed the boundaries of therapeutic innovation, particularly in the realm of immunotherapy. BioNTech’s BNT327, a bispecific antibody targeting vascular endothelial growth factor (VEGF) and Programmed death-ligand 1 (PD-L1), represents a cutting-edge approach to treating difficult cancers such as triple-negative breast cancer (TNBC).[…]

Featured image of the article Arcturus Therapeutics Achieve EMA Approval Recommendation for KOSTAIVE®, a Breakthrough Self-Amplifying RNA Vaccine.

Arcturus Therapeutics Achieve EMA Approval Recommendation for KOSTAIVE®, a Breakthrough Self-Amplifying RNA Vaccine

Posted on by

SOPHIA ANTIPOLIS, France – February 04, 2025 │ KnowMade actively tracks therapeutic mRNA innovations as part of its Therapeutic mRNA patent monitoring services. What’s new today? CHMP Recommends Approval of KOSTAIVE® (ARCT-154) EMA opinion The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval[…]

Featured image of the article Patenting Activity in 2024: An Insightful Analysis.

Patenting Activity in 2024: An Insightful Analysis

Posted on by

SOPHIA ANTIPOLIS, France – January 30, 2025 │ The last quarterly report for the 2024 Therapeutic mRNA patent monitor is now available! As we leave behind another year, we look back on the mRNA therapeutic patenting activity! The year 2024 marked another dynamic period for technological innovation in mRNA therapeutic area, the race for intellectual[…]

Featured image of the article AGS Therapeutics: The French Biotech Disrupting mRNA Delivery with Microalgae Tech.

AGS Therapeutics: The French Biotech Disrupting mRNA Delivery with Microalgae Tech

Posted on by

SOPHIA ANTIPOLIS, France – November 05, 2024 │ The last quarterly report for the 2024 Therapeutic mRNA patent monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. AGS Therapeutics: Pioneering Microalgae-Based Drug Delivery for Therapeutic mRNA AGS therapeutic, a French newcomer to follow Identified[…]